The rationale for the development of antithrombotic, antimetastatic and fibrinolytic drugs: a mechanic point of view.
D000818:Animals; D000970:Antineoplastic Agents; D005343:Fibrinolytic Agents; D006801:Humans
D000970:Antineoplastic Agents; D005343:Fibrinolytic Agents